Physician profile
Patrick L Basile
NPI 1487664124
$95,877.60
in general payments reported to CMS, 2019-2025
20 companies · $3,952 in 2025
The $3,952 reported for 2025 was more than what 91% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,577 · 2020: $542 · 2021: $4,748 · 2022: $42K · 2023: $17K · 2024: $20K · 2025: $3,952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Consulting Fee: $11K · Food and Beverage: $6,180 · Travel and Lodging: $5,486 · Education: $25.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,608.30 |
| Consulting Fee | $10,900.00 |
| Food and Beverage | $6,180.11 |
| Travel and Lodging | $5,486.20 |
| Education | $25.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $44,727.50 | 2019-2022 | |
| Abbvie INC. | $38,759.60 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps, Botox |
| Integra Lifesciences Corporation | $6,201.39 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Surgical Innovation Associates, INC. | $3,201.70 | 2022 | |
| Sientra, INC. | $673.78 | 2020-2022 | |
| Sanara Medtech INC. | $309.59 | 2020-2022 | |
| Motiva USA, LLC | $304.32 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $297.63 | 2019-2025 | Gore Enform Preperitoneal Biomaterial |
| Tela Bio, INC. | $233.73 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $191.67 | 2022-2023 | Irrisept |
| Galderma Laboratories, L.P. | $179.04 | 2021-2024 | |
| Mentor Worldwide LLC | $176.53 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Progenacare Global, LLC | $157.23 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $154.40 | 2019-2023 | Iovera, Exparel |
| Next Science LLC | $103.01 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wound Management Technologies, INC | $54.79 | 2019 | |
| Revance Therapeutics, INC. | $46.79 | 2024 | Daxxify |
| Biocomposites INC | $40.83 | 2019 | |
| Solventum Corporation | $32.47 | 2025 | Promogran Prisma, Snap, Prevena |
| Merz North America, INC. | $31.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Basile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.